1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. INTELLIA THERAPEUTICS INC
Intellia Therapeutics Inc
XNAS: NTLA
12.60 0.23 (1.86%)
3.2M
XNAS Volume

XNAS 22 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Intellia Therapeutics Inc is on 03 Jun 2026 for the purpose of Jefferies Global Healthcare Conference See details

Intellia Therapeutics Inc - NTLA - stock price prediction, stock price target, analyst ratings from 24 analysts

Intellia Therapeutics Inc has a share price target of US$ 27, revenue growth forecast of -10.7%, and profit growth estimate of -0.8% for FY26, based on top 24 analyst calls.